Facing this challenge, we recently successfully isolated GSCs from three GBM patients and enriched the GSC pool by serial trypsinization as well as exposure to epithelial growth factor (EGF) and basic fibroblast growth factor (bFGF) [40], in accordance with our own and other previous findings [41,42,43]. The gene discussed is FGF2; the disease is glioblastoma.